Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Whitehawk Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +2 vs. Q2 2025
- Shares held
- 28.8M
- −601.7K (−2.0%) vs. Q2 2025
- Total value
- $54.3M
- −$267.5K (−0.5%) vs. Q2 2025
- New holders
- 5
- 5 more added
- Sold out
- 3
- 10 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WHWK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 77 | $198.0M |
| Q1 2026 | 62 | $118.2M |
| Q4 2025 | 48 | $79.2M |
| Q3 2025 | 41 | $54.3M |
| Q2 2025 | 39 | $54.6M |
| Q1 2025 | 50 | $56.2M |
| Q4 2024 | 53 | $47.2M |
| Q3 2024 | 52 | $24.7M |
| Q2 2024 | 65 | $16.7M |
| Q1 2024 | 60 | $30.9M |
| Q4 2023 | 65 | $25.8M |
| Q3 2023 | 73 | $75.3M |
| Q2 2023 | 67 | $100.8M |
| Q1 2023 | 70 | $106.6M |
| Q4 2022 | 76 | $192.2M |
| Q3 2022 | 68 | $212.1M |
| Q2 2022 | 68 | $159.3M |
| Q1 2022 | 55 | $213.8M |
| Q4 2021 | 46 | $294.2M |
| Q3 2021 | 33 | $324.1M |
| Q2 2021 | 43 | $51.0M |
| Q1 2021 | 42 | $34.3M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Whitehawk Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| QVT Financial LP | 4,615,709 | $8.33M | 0.92% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,166,000 | $7.92M | 0.19% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,700,000 | $7.03M | 0.21% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 3,410,402 | $6.48M | 6.70% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 2,849,402 | $5.41M | 0.07% | 00.0% | Unchanged |
| Siren, L.L.C. | 2,082,000 | $3.96M | 0.15% | 00.0% | Unchanged |
| Fan Yu | 2,070,000 | $3.93M | 5.12% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,342,907 | $2.55M | 0.00% | +27,622+2.1% | Added |
| Acorn Capital Advisors, LLC | 1,139,363 | $2.16M | 1.10% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 817,939 | $1.55M | 1.30% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 457,422 | $869.1K | 0.00% | −800−0.2% | Reduced |
| StemPoint Capital LP | 424,082 | $805.8K | 0.16% | +424,082 | New |
| Geode Capital Management, LLC | 381,754 | $725.7K | 0.00% | +9,420+2.5% | Added |
| Peapod Lane Capital LLC | 303,585 | $577.1K | 0.52% | +61,375+25.3% | Added |
| BlackRock, Inc. | 296,158 | $562.7K | 0.00% | −2,162−0.7% | Reduced |
| Bridgeway Capital Management, LLC | 215,284 | $409.0K | 0.01% | −100,000−31.7% | Reduced |
| Citadel Advisors LLC | 140,220 | $266.4K | 0.00% | +111,682+391.3% | Added |
| Squarepoint Ops LLC | 83,660 | $159.0K | 0.00% | +22,294+36.3% | Added |
| Northern Trust Corp | 72,164 | $137.1K | 0.00% | −20,111−21.8% | Reduced |
| State Street Corp | 68,737 | $130.6K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 44,115 | $83.8K | 0.00% | −26,634−37.6% | Reduced |
| Stonepine Capital Management, LLC | 35,253 | $67.0K | 0.05% | +35,253 | New |
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $50.7K | 100.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 26,206 | $49.0K | 0.00% | +26,206 | New |
| Jane Street Group, LLC | 25,215 | $47.9K | 0.00% | −80,095−76.1% | Reduced |
| XTX Topco Ltd | 19,780 | $37.6K | 0.00% | +19,780 | New |
| UBS Group AG | 5,693 | $10.8K | 0.00% | −2,980−34.4% | Reduced |
| US Bancorp | 3,333 | $6.33K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 3,070 | $5.89K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,849 | $3.51K | 0.00% | −154−7.7% | Reduced |
| Bartlett & Co. Wealth Management LLC | 1,333 | $2.53K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 797 | $1.51K | 0.00% | −3,301−80.6% | Reduced |
| JPMorgan Chase & Co | 421 | $800 | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 386 | $733 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 232 | $443 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 160 | $304 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 46 | $87 | 0.00% | −365−88.8% | Reduced |
| SBI Securities Co., Ltd. | 19 | $36 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 8 | $15 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 35 | $0 | 0.00% | +35 | New |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −1,091,417−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,103−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −358−100.0% | Sold out |